Collectively, our Western blot analysis of p62 and LC3-I/LC3-II levels in the tumor extracts suggest that RAGE inhibition reduced gemcitabine-induced autophagy in these pancreatic tumors. The gene discussed is MAP1LC3A; the disease is pancreatic neoplasm.